Quarterly net revenue increases to $2.4 million for Alimera

Alimera Sciences reported $2.4 million in net revenue in the third quarter, a 211% increase from $760,000 in the third quarter of the previous year, according to a press release.The company attributed the increase to higher use of Iluvien (fluocinolone acetonide intravitreal implant) in Germany and the United Kingdom.